AbbVie Inc beat Wall Street
estimates for fourth-quarter profit on Friday, helped by a
smaller-than-expected decline in sales of its blockbuster drug,
Humira, and strong demand for Botox amid stiff...

Related Keywords

Bengaluru , Karnataka , India , Leroy Leo , Maju Samuel , Reuters , Abbvie Inc , Vie Inc , Wall Street , Cerevel Therapeutics , Revance Therapeutics , Markets ,